Tradestie Institutional Equity Comparison Engine

IMMX vs SGMO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IMMX Overall Edge

IMMX Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immix Biopharma, Inc. Common Stock (IMMX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SGMO counters with relative strength in Valuation. Fundamentally, IMMX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SGMO at 0.4x Forward P/E and -175.5% operating margin (+88.4% YoY). In options structure, IMMX sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against SGMO sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SGMO
IMMX N/M vs SGMO 0.4x Fwd P/E
Growth & Margin Winner IMMX
Op Margin 0.0% vs -175.5% ยท YoY +0.0% vs +88.4%
Momentum & Technical Winner IMMX
1Y +110.2% vs -76.0% ยท 52W Pos 36% vs 9%
Options & Structure Winner IMMX
BREAKDOWN (17th %ile IV) vs UNCLASSIFIED (71st %ile IV)
IMMX NASDAQ
Immix Biopharma, Inc. Common Stock
Pharmaceutical Preparations
$7.59
-3.19% 1D
Market Cap $655.8M
1M Return -4.89%
1Y Return +110.25%
Forward P/E N/M
Unified AI Score
48.6 / 100 HOLD
Tech 46.0 Fund 55.0 Flow 68.0 Mom 54.0
SGMO NASDAQ
Sangamo Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.18
+31.56% 1D
Market Cap $55.9M
1M Return -40.82%
1Y Return -76.04%
Forward P/E 0.4x
Unified AI Score
52.0 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMMX +110.25% SGMO -76.04% Spread: +223.06 pp (IMMX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IMMX TTM Op. Margin: 0.0% SGMO TTM Op. Margin: -175.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMMX vs SGMO. Trailing 12-month operating profitability (IMMX 0.0% vs SGMO -175.5%) and valuation multiples (IMMX N/M vs SGMO 0.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMMX (5) vs SGMO (4)
Institutional Metric IMMX SGMO Criterion Row Winner
Market Capitalization Scale $655.8M $55.9M Larger Scale IMMX
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple SGMO
Forward P/E Ratio Valuation N/M 0.4x Lower Multiple SGMO
Revenue Growth (YoY) Growth +0.0% +88.4% Higher Growth SGMO
Operating Margin (TTM) Profitability 0.0% -175.5% Higher Margin IMMX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -27.0% -2891.8% Higher ROE IMMX
52-Week Range Position Momentum 36% ($3โ€“$15) 9% ($0โ€“$1) Stronger Trend IMMX
Beta / 30D Volatility Risk Regime 1.80ฮฒ ยท 84% Vol 1.49ฮฒ ยท 206% Vol Lower Realized Risk IMMX
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 52.0 / 100 (HOLD) Higher Composite SGMO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMMX vs SGMO Buy Guide
IMMX BREAKDOWN
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IMMX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGMO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 71st %ile
IV Regime Elevated (60thโ€“80th %ile)
Live SGMO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMMX nor SGMO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.